Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 4
2017 4
2019 3
2020 2
2021 5
2022 9
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Insulin and its single-chain analogue.
Mao R, Chen Y, Chi Z, Wang Y. Mao R, et al. Appl Microbiol Biotechnol. 2019 Nov;103(21-22):8737-8751. doi: 10.1007/s00253-019-10170-0. Epub 2019 Oct 21. Appl Microbiol Biotechnol. 2019. PMID: 31637493 Review.
Removal of patulin by thiol-compounds: A review.
Diao E, Ma K, Qian S, Zhang H, Xie P, Mao R, Song H. Diao E, et al. Among authors: mao r. Toxicon. 2022 Jan 15;205:31-37. doi: 10.1016/j.toxicon.2021.11.010. Epub 2021 Nov 22. Toxicon. 2022. PMID: 34822873 Review.
Type 1 diabetes mellitus and its oral tolerance therapy.
Mao RF, Chen YY, Zhang J, Chang X, Wang YF. Mao RF, et al. World J Diabetes. 2020 Oct 15;11(10):400-415. doi: 10.4239/wjd.v11.i10.400. World J Diabetes. 2020. PMID: 33133388 Free PMC article. Review.
Oral tolerance therapy in type 1 diabetes mellitus.
Mao RF, Chen YY, Diao EJ, Chang X, Chi ZJ, Wang YF. Mao RF, et al. Chin Med J (Engl). 2020 Sep 24;134(1):44-46. doi: 10.1097/CM9.0000000000001130. Chin Med J (Engl). 2020. PMID: 32991369 Free PMC article. No abstract available.
Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE).
Shi Y, Chen J, Yang R, Wu H, Wang Z, Yang W, Cui J, Zhang Y, Liu C, Cheng Y, Liu Y, Shan J, Wang D, Yang L, Hu C, Zhao J, Cao R, Tan B, Xu K, Si M, Li H, Mao R, Li L, Kang X, Wang L. Shi Y, et al. Among authors: mao r. J Thorac Oncol. 2024 Jan 25:S1556-0864(24)00033-9. doi: 10.1016/j.jtho.2024.01.013. Online ahead of print. J Thorac Oncol. 2024. PMID: 38280448 Free article.
The cytotoxicity study of praziquantel enantiomers.
Sun Q, Mao R, Wang D, Hu C, Zheng Y, Sun D. Sun Q, et al. Among authors: mao r. Drug Des Devel Ther. 2016 Jun 24;10:2061-8. doi: 10.2147/DDDT.S98096. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27445457 Free PMC article.
28 results